REQUEST A DEMO
Total
USD $0.00
Search more companies

Multilineas Farmaceuticas S.A. DE C.V. (Mexico)

Main Activities: Plastics Packaging Film and Sheet (including Laminated) Manufacturing
Full name: Multilineas Farmaceuticas S.A. DE C.V. Profile Updated: May 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Multilineas Farmaceuticas S.A. DE C.V. is a company in Mexico, with a head office in Zapopan. The company operates in the Plastics Packaging Film and Sheet (including Laminated) Manufacturing industry. The enterprise was incorporated on June 07, 1980. It currently has a total number of 12 (2022) employees. The latest financial highlights indicate a net sales revenue increase of 36.35% in 2021. There was a total growth of 11.65% in Multilineas Farmaceuticas S.A. DE C.V.’s total assets over the same period. The net profit margin of Multilineas Farmaceuticas S.A. DE C.V. decreased by 2.67% in 2021.

Headquarters
Pino Suarez 1039 Bodega 7, Col. El Vigia
Zapopan; Jalisco; Postal Code: 45140

Contact Details: Purchase the Multilineas Farmaceuticas S.A. DE C.V. report to view the information.

Website: http://www.webexpress3.com

Basic Information
Total Employees:
Purchase the Multilineas Farmaceuticas S.A. DE C.V. report to view the information.
Outstanding Shares:
Purchase the Multilineas Farmaceuticas S.A. DE C.V. report to view the information.
Incorporation Date:
June 07, 1980
Key Executives
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Multilineas Farmaceuticas S.A. DE C.V. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MXN. Absolute financial data is included in the purchased report.
Net sales revenue
36.35%
Total operating revenue
36.35%
Operating profit (EBIT)
41.39%
Net Profit (Loss) for the Period
6.2%
Total assets
11.65%
Total equity
24.49%
Operating Profit Margin (ROS)
0.65%
Net Profit Margin
-2.67%
Return on Equity (ROE)
-3.38%
Debt to Equity Ratio
N/A
Quick Ratio
1.23%
Cash Ratio
1.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?